Arecor Therapeutics (AREC) Stock Chart & Stock Price History GBX 62.10 +3.10 (+5.25%) As of 11:34 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Arecor Therapeutics Stock Price Performance The Arecor Therapeutics (AREC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.13%, with a year-to-date return of -15.80%. In the past month, the stock has increased 30.27%, reflecting recent market activity. As of the latest close, Arecor Therapeutics traded at GBX 60 with a market cap of £22.65 million and volume of 52,729 shares. Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.07%1 Month Performance+30.27%3 Month Performance+63.42%Year-To-Date Performance-15.80%1 Year Performance-32.13% AREC Stock Chart for Friday, August, 8, 2025 AREC Chart by TradingView Arecor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025GBX 58.55GBX 60+2.47%GBX 60GBX 58.5552,729 shs£22.65 million08/06/2025GBX 59.89GBX 58.55-2.24%GBX 59.89GBX 58.5528,045 shs£22.11 million08/05/2025GBX 59.55GBX 59.89+0.57%GBX 60.50GBX 59.78137,462 shs£22.61 million08/04/2025GBX 58GBX 59.55+2.67%GBX 60GBX 57120,439 shs£22.48 million08/01/2025GBX 57GBX 58+1.75%GBX 58GBX 5515,554 shs£21.90 million07/31/2025GBX 56.33GBX 57+1.18%GBX 57.75GBX 56.3361,101 shs£21.52 million07/30/2025GBX 56GBX 56.33+0.59%GBX 57GBX 5415,000 shs£21.27 million07/29/2025GBX 56GBX 56GBX 56GBX 54.1521,600 shs£21.14 million07/28/2025GBX 56.88GBX 56-1.55%GBX 56GBX 54.6623,778 shs£21.14 million07/25/2025GBX 55GBX 56.88+3.42%GBX 56.88GBX 5411,396 shs£21.48 million Get the Latest News and Ratings for AREC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025GBX 52.40GBX 55+4.96%GBX 55GBX 52115,795 shs£20.77 million07/23/2025GBX 51.95GBX 52.40+0.87%GBX 53GBX 52.4076,113 shs£19.78 million07/22/2025GBX 49.50GBX 51.95+4.95%GBX 51.95GBX 49.1096,246 shs£19.62 million07/21/2025GBX 49.30GBX 49.50+0.41%GBX 49.65GBX 49.1028,834 shs£18.69 million07/18/2025GBX 49GBX 49.30+0.61%GBX 49.30GBX 4818,949 shs£18.61 million07/17/2025GBX 48.12GBX 49+1.83%GBX 50GBX 4857,929 shs£18.50 million07/16/2025GBX 49.37GBX 48.12-2.53%GBX 50GBX 48.1234,202 shs£18.17 million07/15/2025GBX 49.38GBX 49.37-0.02%GBX 49.37GBX 471,412 shs£18.64 million07/14/2025GBX 48.64GBX 49.38+1.52%GBX 49.44GBX 48.0512,358 shs£18.64 million07/11/2025GBX 48.40GBX 48.64+0.50%GBX 48.64GBX 4828,474 shs£18.37 million07/10/2025GBX 48.40GBX 48.40GBX 48.40GBX 47.503,088 shs£18.27 million07/09/2025GBX 47.67GBX 48.40+1.53%GBX 48.40GBX 47.501,446 shs£18.27 million07/08/2025GBX 44GBX 47.67+8.34%GBX 47.70GBX 45553,861 shs£18.00 million07/07/2025GBX 44.50GBX 44-1.12%GBX 46.87GBX 44356,977 shs£16.61 million Related Companies hVIVO Stock Price Chart Futura Medical Stock Price Chart SkinBioTherapeutics Stock Price Chart Tissue Regenix Group Stock Price Chart Sareum Stock Price Chart Poolbeg Pharma Stock Price Chart OptiBiotix Health Stock Price Chart IXICO Stock Price Chart Oxford BioDynamics Stock Price Chart Fusion Antibodies Stock Price Chart Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AREC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
